Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
10,56 USD | +2,23% | -9,90% | -3,56% |
13/03 | Top premarket dalers | MT |
12/03 | ITEOS THERAPEUTICS, INC. : JPMorgan Chase herhaalt koopadvies voor het aandeel | ZM |
Vakgebied
Aantal werknemers: 157
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Cancer Immunotherapies
100,0
%
| 268 | 100,0 % | 13 | 100,0 % | -95,29% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States and Belgium
100,0
%
| 268 | 100,0 % | 13 | 100,0 % | -95,29% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Michel Detheux
FOU | Founder | 57 | 01-04-12 |
Matthew Gall
DFI | Director of Finance/CFO | 47 | 01-06-20 |
Yvonne McGrath
CTO | Chief Tech/Sci/R&D Officer | 50 | 01-05-20 |
Matthew Call
COO | Chief Operating Officer | 51 | 01-08-19 |
Adi Osovsky
LAW | General Counsel | - | 01-06-21 |
Human Resources Officer | - | 01-01-20 | |
Bronson Crouch
PRN | Corporate Officer/Principal | 51 | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ann Rhoads
BRD | Director/Board Member | 58 | 01-06-20 |
David Hallal
CHM | Chairman | 57 | 01-06-18 |
Director/Board Member | 52 | 01-06-18 | |
Jill DeSimone
BRD | Director/Board Member | 68 | 07/03 |
Michel Detheux
FOU | Founder | 57 | 01-04-12 |
Robert Iannone
BRD | Director/Board Member | 57 | 03-05-21 |
Tony Ho
BRD | Director/Board Member | 58 | 03-05-21 |
Aaron Davis
BRD | Director/Board Member | 45 | 01-03-20 |
David Lee
BRD | Director/Board Member | - | 05/12 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 35 843 131 | 35 648 970 ( 99,46 %) | 0 | 99,46 % |
Bedrijfsgegevens
Sector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-3,56% | 379 mln. | |
-3,10% | 102 mld. | |
+2,11% | 96,37 mld. | |
-1,80% | 21,37 mld. | |
-17,75% | 20,92 mld. | |
-6,91% | 18,64 mld. | |
-42,00% | 16,4 mld. | |
-28,19% | 13,53 mld. | |
+0,18% | 13,28 mld. | |
+19,90% | 10,85 mld. |
- Beurs
- Aandelen
- Koers ITOS
- Onderneming iTeos Therapeutics, Inc.